Access the full text.
Sign up today, get DeepDyve free for 14 days.
R. Bertina (2001)
Genetic Approach to ThrombophiliaThrombosis and Haemostasis, 86
I. Graham, Leslie Daly, H. Refsum, Killian Robinson, L. Brattström, P. Ueland, R. Palma-Reis, G. Boers, Richard Sheahan, Bo Israelsson, C. Uiterwaal, R. Meleady, Dorothy McMaster, Petra Verhoef, J. Witteman, P. Rubba, Hélène Bellet, Jan Wautrecht, Harold Valk, A. Luis, Francoise Parrot-Roulaud, Kok Tan, I. Higgins, Danielle Garcon, Maria Medrano, Mirande Candito, Alun Evans, Generoso Andria (1997)
Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.JAMA, 277 22
S. Ascani, E. Sabattini, C. Agostinelli, P. Piccaluga, P. Zinzani, S. Pileri (1998)
Erythrophagocytosis by neoplastic cells in a patient with myelodysplastic syndrome.Haematologica, 89
D. Savage, J. Lindenbaum, S. Stabler, R. Allen (1994)
Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies.The American journal of medicine, 96 3
C. Chui, F. Lau, R. Wong, O. Soo, Chuk Lam, P. Lee, Ho Leung, Chiu So, W. Tsoi, N. Tang, Wai Lam, G. Cheng (2001)
Vitamin B12 deficiency--need for a new guideline.Nutrition, 17 11-12
C. Boushey, S. Beresford, G. Omenn, A. Motulsky (1995)
A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes.JAMA, 274 13
David Curtis, R. Sparrow, L. Brennan, M. Weyden (1994)
Elevated serum homocysteine as a predictor for vitamin B12 or folate deficiencyEuropean Journal of Haematology, 52
Uido, Chnyder, Arco, Offi, Vonne, Lammer, Elmut, Angé, Ranz, E. R., Berli, Ernhard, eier (2001)
DECREASED RATE OF CORONARY RESTENOSIS AFTER LOWERING OF PLASMA HOMOCYSTEINE LEVELS
F. Rosendaal (1997)
Risk factors for venous thrombosis: prevalence, risk, and interaction.Seminars in hematology, 34 3
Rosenblatt Ds, Whitehead Vm (1999)
Cobalamin and folate deficiency : Acquired and hereditary disorders in childrenSeminars in Hematology, 36
B. Wharton, I. Booth (2001)
Fortification of flour with folic acidBMJ : British Medical Journal, 323
M. Carrasco, Á. Remacha, A. Sureda, P. Sardà, R. Martino, J. Sierra (1999)
Acute megaloblastic anemia: homocysteine levels are useful for diagnosis and follow-up.Haematologica, 84 8
Á. Remacha, J. Cadafalch (1999)
Cobalamin deficiency in patients infected with the human immunodeficiency virus.Seminars in hematology, 36 1
An, Rik, Ordrehaug, Elga, Efsum, tein, Mil, Ollset (2000)
PLASMA HOMOCYSTEINE LEVELS AND MORTALITY IN PATIENTS WITH CORONARY ARTERY DISEASE
Christopher Snow (1999)
Laboratory diagnosis of vitamin B12 and folate deficiency: a guide for the primary care physician.Archives of internal medicine, 159 12
G. Leone, S. Sica, P. Chiusolo, L. Teofili, V. Stefano (2001)
Blood cells diseases and thrombosis.Haematologica, 86 12
Gruppo Policitemia (1995)
Polycythemia Vera: The Natural History of 1213 Patients Followed for 20 YearsAnnals of Internal Medicine, 123
Armando D’Angelo (1997)
Homocysteine and thrombotic disease.Blood, 90 1
Christine Pfeiffer, D Huff, S Smith, Dayton Miller, Elaine Gunter (1999)
Comparison of plasma total homocysteine measurements in 14 laboratories: an international study.Clinical chemistry, 45 8 Pt 1
J. Mateo, A. Oliver, M. Borrell, N. Sala, J. Fontcuberta (1997)
Laboratory Evaluation and Clinical Characteristics of 2,132 Consecutive Unselected Patients with Venous Thromboembolism – Results of the Spanish Multicentric Study on Thrombophilia (EMET*-Study)Thrombosis and Haemostasis, 77
William Beck (1991)
Diagnosis of megaloblastic anemia.Annual review of medicine, 42
Y. Gonzalez, J. Souto, J. Mateo, A. Córdoba, F. Blanco-Vaca, J. Fontcuberta (1998)
Moderate hyperhomocysteinemia is a highly prevalent defect in Spanish patients with venous thromboembolic disease.Haematologica, 83 12
R. Green (1995)
6 Metabolite assays in cobalamin and folate deficiencyBaillière's clinical haematology, 8
B. Vester, K. Rasmussen (1991)
High Performance Liquid Chromatography Method for Rapid and Accurate Determination of Homocysteine in Plasma and Serum, 29
John Matthews (1995)
Cobalamin and folate deficiency in the elderly.Bailliere's clinical haematology, 8 3
M. Verhaar, E. Stroes, Ton Rabelink (2002)
Folates and Cardiovascular DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 22
Per, M., Ueland, Helga, Refsum, Sally, P. Stabler, Rene, Malinow (1993)
Total homocysteine in plasma or serum: methods and clinical applications.Clinical chemistry, 39 9
I. Fermo, E. Vecchi, C. Arcelloni, A. D’Angelo, R. Paroni (1997)
Methodological aspects of total plasma homocysteine measurement.Haematologica, 82 2
R. Green (1995)
Metabolite assays in cobalamin and folate deficiency.Bailliere's clinical haematology, 8 3
A number of studies have identified elevated levels of homocysteine (Hcy) as a risk factor for thrombosis. Given the relationship between Hcy and thrombosis, a high prevalence of thrombosis would be expected in patients with megaloblastic anemia. The aim of our study was to determine whether an acquired vitamin B 12 /folate deficiency is a risk factor for thrombosis. A retrospective case and control study was performed that included 193 cases with reduced levels of vitamin B 12 /folate. The cases were divided initially into two groups (105 with serum vitamin B 12 ≤150 pmol/l and/or low red cell folate ≤450 nmol/l and 88 with serum vitamin B 12 between 150 and 200 pmol/l and/or red cell folate between 450 and 590 nmol/l). The control group consisted of 87 additional patients who had normal levels of serum vitamin B 12 , red cell folate, and normal renal function. Serum Hcy, thrombotic events, and risk factors were evaluated in all participants. Eight patients (9%) in the control group had had previous vascular events although only three of these events (37.5%) were observed between the vitamin study and 2 years prior to the study. In the case group, 20% of the patients had a history of thrombosis. In contrast with controls, 85% of cases suffered thrombosis between the time they were diagnosed and 2 years prior to the time they were diagnosed as showing a vitamin deficiency. Multivariate analysis demonstrated that vitamin deficiency was a significant risk factor for arterial thrombosis (adjusted odds ratio (OR) 3.3, confidence interval (CI) 1.1–10.2). However, when hyperhomocysteinemia was included in the analysis, vitamin deficiency was no longer a risk factor, suggesting that hyperhomocysteinemia was responsible for arterial thrombotic risk in these patients (adjusted OR 2.5, CI 1.1–5.8). As a consequence of hyperhomocysteinemia, patients with acquired vitamin deficiency of vitamin B 12 /folate had a high risk of thrombosis. However, a more extensive study that controls risk variables and genetic factors is needed to sort out the various contributing factors.
Annals of Hematology – Springer Journals
Published: Nov 1, 2002
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.